Kopran Limited (KOPRAN) Share Price & AI Investment Analysis

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, penicillin, quinolone, anti-protozoal, sulphonamides, respiratory, tetracycline, cardiovascular, anti-diabetic, urology, pain management and anti-inflammatory, gast. Track Kopran Limited's live NSE:KOPRAN share price ₹279.42 (+1.08%), market cap ₹₹14B, P/E 53.9. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for KOPRAN — real-time NSE India stock intelligence.